Barclays
VANI icon

Barclays’s Vivani Medical VANI Stock Holding History

Barclays’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9
Closed -$13 – 5715
2025
Q3 		$13 Buy
+9
New +$12 ﹤0.01% 5384
2017
Q2 		– Sell
-89
Closed -$2K – 6961
2017
Q1 		$2K Sell
89
-32
-26% -$1.23K ﹤0.01% 6501
2016
Q4 		$6K Buy
121
+117
+2,925% +$6.68K ﹤0.01% 6097
2016
Q3 		$0 Sell
4
-44
-92% -$3.89K ﹤0.01% 6809
2016
Q2 		$4K Buy
48
+47
+4,700% +$4.89K ﹤0.01% 5806
2016
Q1 		$0 Buy
+1
New +$115 ﹤0.01% 6456
2015
Q4 		– Sell
-3
Closed – – 6609
2015
Q3 		$0 Sell
3
-6
-67% -$1.67K ﹤0.01% 7067
2015
Q2 		$3K Buy
9
+4
+80% +$1.28K ﹤0.01% 6704
2015
Q1 		$1K Sell
5
-5
-50% -$1.39K ﹤0.01% 6992
2014
Q4 		$2K Buy
+10
New +$3.49K ﹤0.01% 7124

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Barclays's VANI Position: Q4 2025 in Review

Barclays sold out of Vivani Medical (VANI) in Q4 2025, closing a stake of 9 shares — an estimated $13 sold.

Barclays first reported a position in VANI in Q4 2014 and held it in 10 quarters. The position peaked at $6K in Q4 2016. 35 funds tracked by Wall St. Rank hold VANI as of Q4 2025.

  • Barclays reported no remaining Vivani Medical position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 9 Vivani Medical shares in Q4 2025, an estimated $13.
  • Barclays first reported a position in Vivani Medical in Q4 2014 and held it in 10 quarters.
  • Barclays's Vivani Medical position peaked at $6K in Q4 2016.
  • 35 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.